Lupkynis Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

lupkynis

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - Ónæmisbælandi lyf - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

Cernevit Stungulyfsstofn, lausn Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

cernevit stungulyfsstofn, lausn

baxter medical ab* - vítamín a (palmítat); colecalciferolum inn; vítamín e (tocoferolum nfn); acidum ascorbicum inn; thiaminum cocarboxylase tetrahýdrat; riboflavinum natríumfosfat díhýdrat; pyridoxinum hýdróklóríð; cyanocobalaminum inn; acidum folicum inn; dexpanthenolum inn; biotinum inn; nicotinamidum inn - stungulyfsstofn, lausn

Duta Tamsaxiro Hart hylki 0,5/0,4 mg Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

duta tamsaxiro hart hylki 0,5/0,4 mg

medical valley invest ab - dutasteridum inn; tamsulosinum hýdróklóríð - hart hylki - 0,5/0,4 mg